Preparation and Quality Standard Analysis of Coptidis Rhizoma Pieces Standard Decoction

CUI Wen-jin; JIAO Meng-jiao; DENG Zhe; ZHANG Jun; FENG Wei-hong; LIU An

doi:10.13422/j.cnki.syfjx.2017190040

您当前的位置：

首页 >

文章列表页 >

Preparation and Quality Standard Analysis of Coptidis Rhizoma Pieces Standard Decoction

更新时间：2024-01-04

- Preparation and Quality Standard Analysis of Coptidis Rhizoma Pieces Standard Decoction
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 19, Pages: 40-45(2017)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2017190040
  CLC： R283.6;R286.0
- Published：2017
- 稿件说明：
移动端阅览
CUI Wen-jin, JIAO Meng-jiao, DENG Zhe, et al. Preparation and Quality Standard Analysis of Coptidis Rhizoma Pieces Standard Decoction[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(19): 40-45.
DOI：

CUI Wen-jin, JIAO Meng-jiao, DENG Zhe, et al. Preparation and Quality Standard Analysis of Coptidis Rhizoma Pieces Standard Decoction[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(19): 40-45. DOI： 10.13422/j.cnki.syfjx.2017190040.

摘要

目的：制备黄连饮片标准汤剂并建立其质量标准，为黄连配方颗粒的制备及其质量标准的建立提供参考。方法：根据中药饮片标准汤剂制备原则制备黄连饮片标准汤剂，计算表小檗碱、盐酸黄连碱、盐酸巴马汀和盐酸小檗碱的转移率和饮片出膏率，建立黄连饮片标准汤剂的质量标准。流动相乙腈-0.05 mol ·L-1磷酸二氢钾溶液（50：50）（每100 mL中加十二烷基硫酸钠0.4 g，以磷酸调节pH 3.0），柱温30℃，流速1 mL ·min-1，检测波长225 nm。结果：黄连饮片中表小檗碱、盐酸黄连碱、盐酸巴马汀和盐酸小檗碱的转移率范围分别为79.3%~111.9%，54.6%~76.2%，45.7%~70.7%和43.5%~64.4%，出膏率范围17.1%~22.3%，14批黄连饮片标准汤剂特征图谱中有7个共有峰，其相似度均>0.999。结论：该研究建立的质量评价方法精密度和重复性良好，指纹图谱相似度高，适用于黄连饮片标准汤剂的质量评价。

Abstract

Objective: To prepare Coptidis Rhizoma pieces standard decoction and establish its quality standard. Method: According to the standard of Chinese herbal medicine decoction preparation principle

Coptidis Rhizoma pieces standard decoction was prepared

the transfer rates of epiberberine

coptisine hydrochloride

palmatine hydrochloride and berberine hydrochloride and the extract rate were calculated.The quality standard of this standard decoction was also established. Result: The transfer rates of epiberberine

coptisine hydrochloride

palmatine hydrochloride and berberine hydrochloride were 79.3%-111.9%

54.6%-76.2%

45.7%-70.7% and 43.5%-64.4%

respectively;and the extract rate was 17.1%-22.3%.Moreover

7 common peaks were determined in 14 batches of Coptidis Rhizoma pieces standard decoction.The similarities of samples were all higher than 0.999. Conclusion: The method displays good precision

stability and repeatability in fingerprint analysis

which is suitable for the quality evaluation of Coptidis Rhizoma pieces standard decoction.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Study on Division and Change of Main Alkaloids from in Lichuan Hubei at Different Growth Stages

Investigation of Time Change Rule of Compositions Derived from Coptidis Rhizoma Absorbed into the Blood

Optimization of Utrafiltration Purification Technology of Extract

Simultaneous Determination of Four Kinds of Alkaloid from Rhizoma Coptidis in Rat Plasma by LC-MS/MS

Simultaneous Determination of Six Alkaloids in Coptidis Rhizoma and Jinqi Jiangtang Tablets by Double Wavelengths and HPLC

Related Author

ZENG Ye

WANG Xue-kui

XUE Xiang-nan

SI Hai-qian

SUN Xian-zhong

TU Dai-qun

LU Fang

CHEN Ping-ping

Related Institution

Institute of Traditional Chinese Medicine (TCM),Tianjin University of TCM

Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences, Beijng

Sunflower Pharmaceutical Group (Xiangyang) Longzhong Co. Ltd.,Xiangyang

School of Pharmacutical Science, Changchun University of Chinese Medicine

College of Biotechnology, Tianjin University of Science & Technology

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰